The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19
Clinical trial NCT04898985 · SUSPENDED
Trial details
- NCT number
- NCT04898985
- Sponsor
- Larry Saltzman, MD
- Status
- SUSPENDED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-20
- Primary completion
- 2031-05-20
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.